Indefinite Delivery Contract SPE2DB24D9314

The federal contract IDV award, SPE2DB24D9314, is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $499,999,999 contract, awarded by the Defense Logistics Agency (DLA), runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide.

Through this IDC, DMS Pharmaceutical Group provides an extensive array of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across multiple therapeutic classes. Examples include flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptive products, oncology drugs, and specialty medications. This contract complements DMS Pharmaceutical Group's separate prime vendor agreements for direct distribution of pharmacy services and prescription drugs to Department of Defense sites. The IDC, awarded under the DLA's SPE2DB program, does not utilize any set-asides and allows the company to serve as a critical pharmaceutical supplier to military medical facilities globally.